Market Overview:
The global gene expression detection kit market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for personalized medicines, rising prevalence of cancer and other diseases, and technological advancements in gene expression detection kits. Based on type, the global gene expression detection kit market can be segmented into predesign type and customized type. The predesign type segment is expected to account for a larger share of the market than the customized type segment during the forecast period. This can be attributed to factors such as lower costs and shorter turnaround times associated with predesigned kits as compared to customized kits. Based on application, the global gene expression detection kit market can be divided into clinics, hospitals, and others (laboratories/research institutes).
Product Definition:
A gene expression detection kit is a laboratory tool used to measure the amount of gene expression in a sample. This information can be used to determine how active a particular gene is and whether it is associated with any diseases or conditions. Gene expression detection kits are important for understanding the role that genes play in health and disease.
Predesign Type:
The global predesign type market size was valued at USD 6.5 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. The growing demand for personalized medicines, rising prevalence of target diseases, increasing R&D activities by biotechnology companies & government organizations and advancement in genetic engineering are some factors that are driving the growth of this market globally.
Customized Type:
Customized type is a technique used to modify or change the specificity of an antibody by attaching an immunospecific epitope to it. It helps in improving the detection ability of western blotting, ELISA, and other such tests.
In case of western blotting, it allows one to detect a protein of interest with greater sensitivity.
Application Insights:
The others application segment held the largest share of more than 70.0% in 2017. This is attributed to the growing adoption of gene expression analysis for other applications such as drug discovery and toxicology screening. Moreover, increasing research collaborations among key companies are expected to further propel market growth over the forecast period. For instance, in April 2018 Illumina collaborated with Thermo Fisher Scientific for developing a kit that would enable researchers to conduct real-time PCR using only a microtiter plate and an automated thermal cycler machine without any additional equipment or consumables costs involved.
This collaboration is aimed at enabling faster disease detection through rapid testing during clinical trials or epidemiological studies at low cost as compared with traditional methods used for similar purposes currently available in the market place.- Prominent players such as Illumina have been focusing on new product development initiatives owing to increased demand from various research applications across several regions globally.
Regional Analysis:
North America dominated the global market in 2017 owing to an increase in the number of clinical trials and a rise in healthcare expenditure. The U.S.-based company, Illumina, has established a strong presence across this region by providing its gene expression analysis tools to numerous researchers and diagnostic laboratories for their research projects and commercial applications.
Asia Pacific is expected to grow at the highest CAGR during the forecast period due to increasing government initiatives for early disease diagnosis coupled with rising awareness about genetic tests among people living in this region.
Growth Factors:
- Increasing demand for personalized medicines
- Growing prevalence of cancer and other diseases
- Technological advancements in gene expression detection kits
- Rising research and development expenditure by pharmaceutical and biotechnology companies
- Growing number of clinical trials
Scope Of The Report
Report Attributes
Report Details
Report Title
Gene Expression Detection Kit Market Research Report
By Type
Predesign Type, Customized Type
By Application
Clinics, Hospitals, Others
By Companies
Thermo Fisher Scientific, Qiagen, OriGene, Bioline, Biocompare, Fluidigm, Genecopoeia, InvivoGen, K.K. DNAFORM, NanoString Technologies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
201
Number of Tables & Figures
141
Customization Available
Yes, the report can be customized as per your need.
Global Gene Expression Detection Kit Market Report Segments:
The global Gene Expression Detection Kit market is segmented on the basis of:
Types
Predesign Type, Customized Type
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinics, Hospitals, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Qiagen
- OriGene
- Bioline
- Biocompare
- Fluidigm
- Genecopoeia
- InvivoGen
- K.K. DNAFORM
- NanoString Technologies
Highlights of The Gene Expression Detection Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Predesign Type
- Customized Type
- By Application:
- Clinics
- Hospitals
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Gene Expression Detection Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Gene Expression Detection Kit is a set of tools that allow for the detection and quantification of gene expression levels in samples.
Some of the key players operating in the gene expression detection kit market are Thermo Fisher Scientific, Qiagen, OriGene, Bioline, Biocompare, Fluidigm, Genecopoeia, InvivoGen, K.K. DNAFORM, NanoString Technologies.
The gene expression detection kit market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Gene Expression Detection Kit Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Gene Expression Detection Kit Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Gene Expression Detection Kit Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Gene Expression Detection Kit Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Gene Expression Detection Kit Market Size & Forecast, 2020-2028 4.5.1 Gene Expression Detection Kit Market Size and Y-o-Y Growth 4.5.2 Gene Expression Detection Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Predesign Type
5.2.2 Customized Type
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Clinics
6.2.2 Hospitals
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Gene Expression Detection Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Gene Expression Detection Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Predesign Type
9.6.2 Customized Type
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Clinics
9.10.2 Hospitals
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Predesign Type
10.6.2 Customized Type
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Clinics
10.10.2 Hospitals
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Predesign Type
11.6.2 Customized Type
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Clinics
11.10.2 Hospitals
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Predesign Type
12.6.2 Customized Type
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Clinics
12.10.2 Hospitals
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Predesign Type
13.6.2 Customized Type
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Clinics
13.10.2 Hospitals
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Gene Expression Detection Kit Market: Competitive Dashboard
14.2 Global Gene Expression Detection Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 Qiagen
14.3.3 OriGene
14.3.4 Bioline
14.3.5 Biocompare
14.3.6 Fluidigm
14.3.7 Genecopoeia
14.3.8 InvivoGen
14.3.9 K.K. DNAFORM
14.3.10 NanoString Technologies